Modern Approaches and Considerations for Designing Real-World Studies
Discover how decentralized study elements, integrated real-world data, and expert analysis plans are redefining modern observational studies.
RWD Data Insights: Linkage of patient services and real-world healthcare data
Explore UBC’s study to see how linking patient support programs and RWD is a source of valuable insights into the patient healthcare journey.
Enriching clinical studies with longitudinal real-world data
Download our case study to explore how UBC linked clinical trial data with six years of pre- and post-trial patient healthcare data, for rich longitudinal real-world evidence development.
FDA Compliant Clinical Trial Diversity Action Plan Checklist
Ensure FDA compliance with a Clinical Trial Diversity Action Plan (DAP). Get strategies for RWD geo-targeting, engagement, and Modernized Study Designs (MSDs).
The Vital Role of Diversity in Clinical Trials
Download our white paper The Vital Role of Diversity in Clinical Trials for a three-pronged approach to help address clinical trial enrollment and participation gaps.
Personalized Medicine: A Primer on the Role of Pharmacogenetics and Pharmacogenomics in Oncology
Explore how pharmacogenetics and genomics are transforming cancer treatment, reducing adverse drug reactions, and advancing targeted therapy development safely.
Recently Approved Cell-Based Gene Therapies Demonstrate Innovation in Sickle Cell Disease Treatment
This white paper offers a comprehensive primer on the burden of SCD, the patient journey, and current and emerging treatment options.
Understanding the Natural History of Disease
Learn more about the benefits of natural history studies in drug development.
The Joint Clinical Assessment: Anticipating Challenges and Opportunities
This white paper provides an essential overview of the regulations, a brief history, and an in-depth look at the EU’s Health Technology Assessment Regulation 2021/2282.
